Jump Financial, LLC Aveo Pharmaceuticals, Inc. Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$6.61 - $8.72 $9,465 - $12,487	1,432 Added 4.68%	32,000 $263,000
Q2 2022 Aug 09, 2022	BUY	$3.51 - $6.67 $107,293 - $203,888	30,568 New	30,568 $201,000
Q1 2022 May 12, 2022	SELL	$3.15 - $6.01 $76,170 - $145,327	-24,181 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$4.69 - $7.4 $113,408 - $178,939	24,181 New	24,181 $113,000
Q3 2021 Nov 12, 2021	SELL	$5.12 - $6.89 $260,608 - $350,701	-50,900 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$6.21 - $7.45 $316,089 - $379,205	50,900 New	50,900 $336,000

Ticker AVEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,676,000
Description
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.